A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice
NCT07556159 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2500
Last updated 2026-04-29
Summary
The main aim of the study to describe the characteristics of participants with asthma across the spectrum of disease severity, including sociodemographic and clinical characteristics, treatment and disease burden, biomarkers, and both disease-specific and generic health-related quality of life.
The study consists of two parts: a cross-sectional study, and a prospective follow-up evaluate changes in disease trajectories in participants with asthma.
Conditions
Interventions
- OTHER
-
Procedure: Investigational Procedures
Participant- and physician-reported outcomes will be collected per protocol. No Investigational Medicinal Product (IMP) administration.
- OTHER
-
Procedure: Investigational Procedures
Participant- and physician-reported outcomes, blood samples/lung tests and other optional assessments will be collected per protocol. No IMP administration.
Sponsors & Collaborators
- collaborator OTHER
- lead INDUSTRY
Eligibility
- Min Age
- 6 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-04-01
- Primary Completion
- 2029-04-04
- Completion
- 2029-04-04
Countries
- United States
Study Locations
More Related Trials
-
Characteristics of Type 2- High Inflammatory Endotype of Asthma Using New Biomarkers From Peripheral Blood and Exhaled Air and Its Effect on the Outcome of Therapy
NCT05270278 ·Status: COMPLETED
-
GSNOR Phenotyping/GSNO Challenge in Severe Asthma
NCT03926741 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Observational and Epidemiologic Study of the Disease Course and Unmet Needs in Children With Symptomatic Moderate to Severe Allergic Asthma
NCT01362621 ·Status: COMPLETED
-
Factors for Predicting Severe Asthma Exacerbators in Adult Asthmatics: A Real Word- Effectiveness Study
NCT04563988 ·Status: COMPLETED
-
Phenotyping Disease Severity in Asthma
NCT05078021 ·Status: RECRUITING
-
Cross-sectional Study for Identification and Description of Severe Asthma Patients
NCT02293265 ·Status: COMPLETED ·Phase: PHASE3
-
A Translational Study to Describe Clinical Characteristics, Biomarkers and to Identify Phenotypes and Endotypes Associated With Differential Outcomes in Chinese Population
NCT06419413 ·Status: RECRUITING
-
An Observational, Prospective, Multicenter Study to Evaluate the Biologic Use and Outcomes in Chinese Asthma Patients
NCT06605885 ·Status: ACTIVE_NOT_RECRUITING
-
A 12-Week Study in Adult Subjects With Asthma
NCT01516086 ·Status: COMPLETED ·Phase: PHASE2
-
Longitudinal Phenotyping and Endotyping Study in Adult Patients With Mild, Moderate, or Severe Asthma
NCT07189806 ·Status: RECRUITING
-
A Study To Estimate The Relative Bioavailability Of PF-00258210 Administered Alone Or In Combination With PF-00610355
NCT01043276 ·Status: COMPLETED ·Phase: PHASE1
-
Study in Mild Asthmatic Patients
NCT00748306 ·Status: COMPLETED ·Phase: PHASE2
-
Follow-up of Mild Eosinophilic Asthma
NCT04650503 ·Status: UNKNOWN
-
Biomarkers in Exhaled Breath From Asthmatic Patients
NCT00635271 ·Status: TERMINATED
-
Study on Patterns of Care in Mild Asthmatic Patients
NCT04598555 ·Status: COMPLETED
-
Phenotyping Responses to Systemic Corticosteroids in the Management of Asthma Attacks
NCT05870215 ·Status: COMPLETED
-
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
NCT00576069 ·Status: RECRUITING
-
Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based Therapy
NCT02502890 ·Status: COMPLETED
-
Seinäjoki Adult Asthma Study
NCT02733016 ·Status: COMPLETED
-
Study With GW274150 In Patients With Mild Asthma
NCT00273013 ·Status: COMPLETED ·Phase: PHASE1
-
Identification of Asthma Phenotypes in Severe Asthmatics
NCT01623089 ·Status: RECRUITING
-
Asthma Biomarker Study
NCT02392481 ·Status: COMPLETED
-
Glasgow Asthma and Allergy Study
NCT01618318 ·Status: COMPLETED
-
Registry of Asthma Patients Initiating DUPIXENT®
NCT04287621 ·Status: ACTIVE_NOT_RECRUITING
-
A Study to Evaluate the Quality of Life in Male and Female Adult Participants With Severe Asthma Treated With Dupilumab in a Real-world Setting
NCT06018441 ·Status: COMPLETED